Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis

Upstream open reading frames: Molecular switches in (patho)physiology

(2010) Klaus Wethmar et al.   BIOESSAYS

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

(2010) Maurice Balke et al.   BMC CANCER

C/EBP  uORF mice--a genetic model for uORF-mediated translational control in mammals

(2010) K. Wethmar et al.   GENES & DEVELOPMENT

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

(2010) David Thomas et al.   LANCET ONCOLOGY

Giant cell tumour of bone

(2009) David M Thomas et al.   CURRENT OPINION IN ONCOLOGY

Transcription factor C/EBPβ isoform ratio regulates osteoclastogenesis through MafB

(2009) Jeske J Smink et al.   EMBO JOURNAL

Rapamycin and the transcription factor C/EBPβ as a switch in osteoclast differentiation: implications for lytic bone diseases

(2009) Jeske J. Smink et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

New drugs in multiple myeloma

(2009) James R Berenson et al.   Current Opinion in Supportive and Palliative Care

The Osteoclast: Friend or Foe?

(2008) Deborah V. Novack et al.   Annual Review of Pathology-Mechanisms of Disease

NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)

(2007) Kabsun Kim et al.   MOLECULAR ENDOCRINOLOGY

Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors

(2006) Gerald J. Atkins et al.   JOURNAL OF BONE AND MINERAL RESEARCH